The object of the present invention is a new process for the synthesis of tapentadol, both as free base and in hydrochloride form, which comprises the step of alkylation of the ketone (VII) to yield the compound (VIII), as reported in Diagram 1, with high stereoselectivity due to the presence of the benzyl group as substituent of the amino group. It was surprisingly found that this substitution shifts the keto-enol equilibrium towards the desired enantiomer and amplifies the capacity of the stereocenter present in the compound (VII) to orient the nucleophilic addition of the organometallic compound at the carbonyl towards the desired stereoisomer. This substitution thus allows obtaining a considerable increase of the yields in this step, and consequently allows significantly increasing the overall yield of the entire tapentadol synthesis process.
A further object of the present invention is constituted by the tapentadol free base in solid form, obtainable by means of the process of the invention.
Still another object of the invention is represented by the crystalline forms I and II of the tapentadol free base.
A further object of the present invention is the mixture of the crystalline forms I and II of the tapentadol free base.
本发明的对象是一种新的制备托瑞哌酮的过程,包括自由基和盐酸盐形式,其中包括烷基化酮(VII)的步骤,以产生化合物(VIII),如图1所示,由于苄基作为
氨基取代基的存在,具有高立体选择性。令人惊讶的是,这种取代使得酮-烯醇平衡向所需的对映体转移,并放大了化合物(VII)中存在的立体中心定向有机
金属化合物在羰基上的亲核加成,以获得所需的立体异构体。这种取代因此允许在这一步骤中获得可观的收率增加,从而显着提高整个托瑞哌酮合成过程的总收率。本发明的另一个对象是由本发明的过程获得的固态托瑞哌酮自由基。本发明的另一个对象是托瑞哌酮自由基的晶体形式I和II。本发明的另一个对象是托瑞哌酮自由基晶体形式I和II的混合物。